Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Keywords
Chronic Obstructive Pulmonary Disease, COPD
Brief summary
This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.
Detailed description
Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-period.
Interventions
BEHAVIORALpharmaceutical care intervention
Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).
Sponsors
University Ghent
GlaxoSmithKline
University Hospital, Ghent
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV) * 50 years of age or older * smoking history of at least 10 pack-years
Exclusion criteria
* having asthma * analphabetism
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| inhalation technique baseline | baseline | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication at baseline. |
| inhalation technique 1 month | after 1 month | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 1 month. |
| inhalation technique 3 months | after 3 months | Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months. |
| drug adherence | after 3 months | Adherence to Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| exacerbations | after 3 months | Frequency of exacerbations measured over a 3 month period. |
| Emergency Room visits and hospitalizations. | after 3 months | Frequency of Emergency Room (ER) visits and hospitalizations measured over a 3 month period. |
| health status | baseline | Health status, measured by: the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test, Medical Research Council (MRC) Dyspnoea Scale and Euro Quality of Life (EQ-5D) questionnaire. |
Countries
Belgium
Outcome results
None listed